NEW YORK (Reuters Health) – A course of intravenous antibiotic therapy lasting no more than 3 days for hospitalized infants with urinary tract infections is just as successful…
NEW YORK (Reuters Health) – In managing hospitalized patients who develop candidemia, the standard practice of promptly removing a central venous catheter does not improve outcomes, according a…
NEW YORK (Reuters Health) – Urinary tract infections occur quite often after patients are given detrusor injections of botulinum toxin A (BoNT-A) to reduce bladder overactivity, so prophylactic…
NEW YORK (Reuters Health) – During the first year of treatment for chronic hepatitis B, tenofovir and entecavir are the most effective antiviral agents available, according to the…
NEW YORK (Reuters Health) – Early, prehospital administration of nebulized 5% saline to infants with acute bronchiolitis reduces illness severity significantly without undue side effects, according to the…
NEW YORK (Reuters Health) – Patients infected with hepatitis C virus (HCV) type 1 who have a slow response to pegylated interferon-alfa and ribavirin can benefit from continuing…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…
NEW YORK (Reuters Health) – Cumulative exposure to particular antiretroviral agents in patients being treated for HIV infection is associated with an increased risk of developing chronic kidney…
NEW YORK (Reuters Health) – The quadrivalent measles-mumps-rubella-varicella vaccine is associated with twice as many febrile seizures as same-day vaccination with separate MMR and varicella vaccines, according to…
NEW YORK (Reuters Health) – The notable accumulation of visceral fat that occurs in some patients with HIV who are on antiretroviral drugs can be reduced substantially by…